Gene · 134864
Papers1,472
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,472
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review. | Pharmaceuticals (Basel) | 2026 | 42797537 | PubTator, text mining | PubMed |
| Thymosin Alpha-1 Provides Direct Neuroprotection by Engaging the Orexin Receptor HCRTR1 to Suppress Neuronal Necroptosis. | Adv Sci (Weinh) | 2026 | 42693587 | PubTator, text mining | PubMed |
| Novel Insights into the Pleiotropic Neuroprotective Action of Synthetic Halogen Free Thyronamine-like Analogues. | Molecules | 2026 | 42653915 | PubTator, text mining | PubMed |
| Thymosin α-1 in cancer therapy: Immunomodulatory mechanisms, clinical applications, and translational perspectives. | Eur J Pharmacol | 2026 | 42641753 | PubTator, text mining | PubMed |
| Concurrent downregulation of TAAR1 and NQO1 in individuals with isolated methamphetamine use: Implications for dopaminergic and oxidative stress-related biology. | Prog Neuropsychopharmacol Biol Psychiatry | 2026 | 42641678 | PubTator, text mining | PubMed |
| Dynamic evolution of retroviral envelope-derived sequences in primates. | Virus Evol | 2026 | 42583397 | PubTator, text mining | PubMed |
| Trace Amine-associated Receptor 1 Agonists for Treatment of Substance use Disorder: Evidence from Rodent Behavioral Studies. | Curr Neuropharmacol | 2026 | 42576581 | PubTator, text mining | PubMed |
| TAAR Immunopharmacology. | Handb Exp Pharmacol | 2026 | 42463873 | PubTator, text mining | PubMed |
| TAAR1 Potential for Treatment of Stress Disorders. | Handb Exp Pharmacol | 2026 | 42463872 | PubTator, text mining | PubMed |
| Sex Differences in Trace Amine-Associated Receptor Signalling. | Handb Exp Pharmacol | 2026 | 42463870 | PubTator, text mining | PubMed |
| TAAR1 as a Potential Alternate Molecular Target to GLP-1 for Novel Anti-diabetic, Anti-obesity Medications. | Handb Exp Pharmacol | 2026 | 42432129 | PubTator, text mining | PubMed |
| Translational Relevance of the Methylazoxymethanol Acetate Model in Schizophrenia: A Systematic Review of Behavioral and Neurobiological Findings. | Biol Psychiatry | 2026 | 42419666 | PubTator, text mining | PubMed |
| Thymosin α1 Augments CD8⁺ T-Cell Activation and Reverses Exhaustion In Vitro. | Asian Pac J Cancer Prev | 2026 | 42345155 | PubTator, text mining | PubMed |
| Medicinal chemistry advances of TAAR1 agonists: SAR, structural innovation, and mechanistic insights. | Eur J Med Chem | 2026 | 42302664 | PubTator, text mining | PubMed |
| Thymosin α1 combined with immune checkpoint inhibitors: synergistic remodeling of the tumor immune microenvironment to enhance clinical efficacy and safety. | Front Immunol | 2026 | 42292432 | PubTator, text mining | PubMed |
| An Exploratory Study of High-Concentration Trace Amine Effects and Adrenoceptor Expression Patterns in SH-SY5Y Cells and Neuroblastoma. | Int J Mol Sci | 2026 | 42278562 | PubTator, text mining | PubMed |
| Thyronines and thyronamines: dual modulators of synaptic plasticity, cognitive decline, and geriatric depression in the aging brain. | Behav Brain Res | 2026 | 42203047 | PubTator, text mining | PubMed |
| Real-world Glycemic Outcomes of a Tubeless Automated Insulin Delivery System (Medtrum A8 TouchCare) in Adults With Type 1 Diabetes. | Can J Diabetes | 2026 | 42176953 | PubTator, text mining | PubMed |
| Precision pharmacology of CNS GPCRs: From biased signaling to translational therapeutics. | Prog Neuropsychopharmacol Biol Psychiatry | 2026 | 42173424 | PubTator, text mining | PubMed |
| The histidine crossroad: An integrative theory of the gut-liver-vascular axis in MASLD. | Biomed Pharmacother | 2026 | 42166982 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/134864/papers